Literature DB >> 9636560

Oral ganciclovir in the prevention of cytomegalovirus infection in postkidney transplant "CMV at risk" recipients: a controlled, comparative study of two regimens (750 mg Bid and 500 mg Bid).

N Ahsan1, M J Holman, L Sonderbye, E Langhoff, H C Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9636560     DOI： 10.1016/s0041-1345(98)00283-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

Authors:  J K McGavin; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice.

Authors:  J A Mauskopf; A Richter; L Annemans; G Maclaine
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

Review 3.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Authors:  Daniel S Owers; Angela C Webster; Giovanni F M Strippoli; Kathy Kable; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

4.  Efficacy and Safety of Antiviral Agents in Preventing Allograft Rejection Following CMV Prophylaxis in High-Risk Kidney Transplantation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Narisa Ruenroengbun; Tunlanut Sapankaew; Kamolpat Chaiyakittisopon; Pakpoom Phoompoung; Thundon Ngamprasertchai
Journal:  Front Cell Infect Microbiol       Date:  2022-04-01       Impact factor: 6.073

5.  Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: a systematic review and network meta-analysis.

Authors:  Narisa Ruenroengbun; Pawin Numthavaj; Tunlanut Sapankaew; Kamolpat Chaiyakittisopon; Atiporn Ingsathit; Gareth J Mckay; John Attia; Ammarin Thakkinstian
Journal:  Transpl Int       Date:  2021-10-28       Impact factor: 3.842
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.